On February 3, with Pfizer (PFE) trading at $25.50, I opened my original LEAP position.
Why I Entered
I originally opened this trade based on:
- ๐ An earnings beat and the stock tanked the same day due to profit taking
- ๐ Consensus that the stock had been beaten down
- ๐ Analyst price targets ranging from $23โ$35 per share
This wasnโt a lottery ticket.
It was a value-based thesis with defined risk.
My expectation was not explosive upside โ but stabilization and recovery within a range.
๐ February 3 โ Original Position
5 ร Jun 17, 2027 $20 Calls
| Metric | Value |
|---|---|
| Underlying Price | $25.50 |
| Strike | $20 |
| Option Price | $7.47 |
| Delta | ~.90 |
| Synthetic Shares | 450 |
| Capital at Risk | $3,735 |
๐งฎ Exposure Math
.90 ร 100 ร 5 = 450 synthetic shares
Capital committed:
$7.47 ร 100 ร 5 = $3,735
At .90 delta, I was essentially long 450 shares.
If PFE went to $0, I could lose $3,735.
That was my maximum defined risk.
๐ง How the Thesis Evolved
Even with analyst targets between $23 and $35, I donโt expect a straight-line move.
My updated working assumptions:
- ๐ฆ PFE likely channels
- ๐ Worst-case realistic scenario around $14
- ๐ฐ Premium harvesting matters more than max delta
Thatโs what led to the roll.
๐ The Roll to $25
I executed:
- Sold 5 $20 Calls @ $7.47
- Bought 5 $25 Calls @ $3.95
๐ฐ Roll Credit
$7.47 โ $3.95 = $3.52 per contract
$3.52 ร 100 ร 5 = $1,760 credit received
Immediate capital reduction.
๐ New Position
5 ร Jun 17, 2027 $25 Calls
| Metric | Value |
|---|---|
| Strike | $25 |
| Option Cost | $3.95 |
| Gross Capital at Risk | $1,975 |
๐งฎ New Gross Risk
$3.95 ร 100 ร 5 = $1,975
That is the maximum loss on the LEAP itself.
๐ฐ Covered Call Income
I also collected:
$150 from selling covered calls.
๐ True Net Capital at Risk
LEAP cost: $1,975
Minus covered call income: $150
= $1,825 net capital exposure
That is my real-world maximum downside today.
๐ Worst-Case Scenarios
If PFE Drops to $20
- $25 calls go OTM
- Delta shrinks
- I still have time (2027 expiration)
- I can continue selling calls
No forced assignment. No surprise purchase.
If PFE Drops to $14 (My Assumed Worst Case)
At expiration:
Calls expire worthless.
Loss = $1,825
If PFE Goes to $0
Same outcome.
Loss = $1,825
Defined risk remains defined.
โ๏ธ Before vs After
| February 3 Position | After Roll + Income | |
|---|---|---|
| Strike | $20 | $25 |
| Delta | .90 | Lower |
| Synthetic Shares | 450 | Reduced |
| Max Loss | $3,735 | $1,825 |
| Capital Freed | โ | $1,760 |
๐ Risk Reduction
$3,735 โ $1,825 = $1,910 less maximum exposure
Thatโs structural compression of risk.
๐ฏ Why This Still Fits the Original Thesis
Analysts see $23โ$35.
That supports upside potential.
But I structured the trade assuming:
- It may stall near $23
- It may grind toward $30
- It may even dip before recovering
I donโt need 450 synthetic shares for that.
I need:
- Efficient exposure
- Reduced capital risk
- Flexibility to harvest premium
๐ Retail Trader Takeaway
If you remember nothing else from this post, remember this:
1๏ธโฃ Delta Is Exposure
A .90 delta LEAP is basically stock.
5 contracts ร .90 delta = 450 synthetic shares
Ask yourself:
Do I really want that much directional exposure for this stock?
2๏ธโฃ Maximum Loss on a Long Call = Premium Paid (Minus Income)
Not the strike.
Not the intrinsic difference.
Not some scary theoretical number.
After the roll and covered call income:
True net max loss = $1,825
Even if PFE goes to $14.
Even if it goes to $0.
Defined risk means defined risk.
3๏ธโฃ Rolling for Credit Can Compress Risk
Before roll:
Max loss = $3,735
After roll + income:
Max loss = $1,825
Thatโs $1,910 less exposure.
Rolling up didnโt increase risk.
It materially reduced it.
4๏ธโฃ Structure Around Your Thesis
My thesis:
- ๐ฆ Channeling stock
- ๐ข Slow movement
- ๐ฐ Premium opportunities
If I believed PFE was about to rip higher, I would have kept the $20 strike and the .90 delta.
Position management should match probability โ not hope.
๐ง Final Thought
Trading LEAPS isnโt about being right.
Itโs about:
- Managing exposure
- Controlling maximum loss
- Improving return on capital
- Surviving the downside
This roll wasnโt exciting.
It was disciplined.
And disciplined trading compounds.


Leave a Reply